U.S. DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTES MARKET ANALYSIS

U.S. Dental Membrane and Bone Graft Substitutes Market, by Product Type (Dental Membrane (Resorbable Membranes and Non-resorbable Membranes) and Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, and Synthetic Bone Graft Substitute)), by Material (Collagen, Hydrogel, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene, Human Cells Source, and Others), by Application (Socket Preservation, Ridge Augmentation, Sinus Lifts, Guided Bone Regeneration (GBR), and Guided Tissue Regeneration (GTR)), and by End User (Hospitals, Dental Clinics, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Nov 2021
Code : CMI4749
Pages :222
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Key Players

Major players operating in the U.S. dental membrane and bone graft substitutes market include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical., Medtronic, and OUSIA.